A Different Kind of Treatment
Most rosacea treatments you will read about on this site work on the underlying condition in some way: azelaic acid and metronidazole reduce inflammation, and laser or IPL physically address visible blood vessels over time.
Brimonidine and oxymetazoline are different. They are vasoconstrictors: they temporarily narrow the small blood vessels near the skin’s surface, which makes diffuse redness less visible for a number of hours. When the effect wears off, the redness returns. The underlying rosacea is unchanged.
That is not a criticism. For many people with erythematotelangiectatic (ETR) rosacea, background redness is the most distressing part of the condition, and having an on-demand option for high-stakes days can matter. But it helps to be clear-eyed about what you are choosing: symptom cover, not disease control.
How Each One Works
Same visible result, slightly different mechanisms.
Brimonidine (Mirvaso)
An alpha-2 adrenergic agonist. It stimulates alpha-2 receptors on the blood vessels in the skin, causing them to constrict. It was developed specifically for the persistent facial redness of rosacea. See our brimonidine guide for more detail.
Oxymetazoline (Rhofade)
An alpha-1A adrenergic agonist. It acts on a different receptor subtype, but the practical result is similar: surface vessels narrow and redness fades temporarily. You may also know oxymetazoline from decongestant nasal sprays; the topical cream uses it in a different form and dose. See our oxymetazoline guide.
In practice, both are applied as a thin pea-sized amount to the areas of persistent redness. Neither should be applied to broken, irritated, or freshly exfoliated skin.
Side-by-Side Comparison
| Brimonidine | Oxymetazoline | |
|---|---|---|
| How it works | Alpha-2 agonist: narrows surface blood vessels | Alpha-1A agonist: narrows surface blood vessels |
| Brand name (UK/US) | Mirvaso | Rhofade (US availability has varied) |
| Main effect | Temporary reduction in diffuse redness | Temporary reduction in diffuse redness |
| Typical duration | Several hours before it wears off | Several hours before it wears off |
| Frequency | Usually applied once daily | Usually applied once daily |
| Rebound redness | Reported more often | Reported less often, but possible |
| Effect on bumps and pustules | None | None |
| Availability | Prescription only | Prescription only |
How it works
Brimonidine: Alpha-2 agonist: narrows surface blood vessels
Oxymetazoline: Alpha-1A agonist: narrows surface blood vessels
Brand name (UK/US)
Brimonidine: Mirvaso
Oxymetazoline: Rhofade (US availability has varied)
Main effect
Brimonidine: Temporary reduction in diffuse redness
Oxymetazoline: Temporary reduction in diffuse redness
Typical duration
Brimonidine: Several hours before it wears off
Oxymetazoline: Several hours before it wears off
Frequency
Brimonidine: Usually applied once daily
Oxymetazoline: Usually applied once daily
Rebound redness
Brimonidine: Reported more often
Oxymetazoline: Reported less often, but possible
Effect on bumps and pustules
Brimonidine: None
Oxymetazoline: None
Availability
Brimonidine: Prescription only
Oxymetazoline: Prescription only
Duration and Once-Daily Use
Both are typically applied once daily. The redness reduction usually begins within around half an hour to an hour and lasts several hours before gradually wearing off. The exact timing varies a lot between individuals, so it is worth learning your own pattern rather than relying on averages.
Because the effect is temporary, timing matters more than with a conventional treatment. Some people apply it in the morning before work; others save it for specific occasions. There is no obligation to use it every day, and if you find you need it constantly just to feel presentable, that is worth raising with your prescriber rather than quietly increasing use.
The Rebound Question
The most discussed drawback of this class of treatment is rebound redness: redness that flares as the vasoconstriction wears off, sometimes appearing worse than before application. This has been reported more often with brimonidine than oxymetazoline, though it can occur with either, and it does not happen to everyone.
Rebound is usually described as a flushing episode in the hours after application. It tends to be most noticeable in the first weeks of use, which is why a cautious introduction matters. If you notice a clear pattern of worsening redness each evening, mention it to your prescriber before deciding whether to continue.
This is not a reason to avoid the category outright. It is a reason to go in informed, start gently, and judge your own response over a few weeks rather than a single day.
Who Each Tends to Suit
A broad pattern, not a rule. Your prescriber will assess your skin.
Brimonidine may suit you if…
You have persistent background redness with ETR-type rosacea, you want an established option with the longer track record, and you have discussed rebound risk with your prescriber. It is the more-studied of the two for facial redness.
Oxymetazoline may suit you if…
You and your prescriber are particularly cautious about rebound redness, or brimonidine has not suited you previously. It works through a different receptor, so skin that reacts to one may tolerate the other better.
Neither may be the priority if…
Your main concern is bumps, pustules, or frequent flushing episodes. These topicals do not address inflammation, and someone with a mostly papulopustular picture will usually be offered a different first-line treatment.
What They Do Not Do
It is worth being precise about the limits of these treatments:
- No effect on papules or pustules — inflammatory bumps need a different approach.
- No effect on the underlying inflammation driving rosacea.
- No lasting change to visible blood vessels (telangiectasia) — the constriction reverses when the cream wears off.
- No effect on trigger sensitivity — heat, alcohol, and stress will still cause flushing.
In other words, these are cosmetic-window treatments. Most dermatologists use them alongside — not instead of — a longer-term plan.
Starting Sensibly
Both treatments come with specific application instructions from the manufacturer and your prescriber. A few general principles are commonly advised, always under your prescriber’s guidance:
- Start small. Use no more than the prescribed amount. More product does not mean more benefit, and thin application reduces irritation risk.
- Patch test first. Ask your prescriber about trying a small area (often behind the ear or on the jawline) before applying to the whole face, and watch the area for a day or two.
- Apply to calm skin. Avoid broken, freshly exfoliated, or actively burning skin, and let any other actives absorb fully first.
- Log what happens. Note redness levels on application, midday, and evening for the first couple of weeks, so any rebound pattern is visible rather than anecdotal.
If anything worsens, stop the product and contact your prescriber. Do not increase frequency on your own to chase a stronger effect.
When to Consider Laser or IPL Instead
If persistent redness and visible blood vessels are your main concern and you are wary of daily medication, it may be worth asking a dermatologist about vascular laser or IPL instead. These address the vessels themselves over a course of sessions, rather than masking them for a few hours at a time. Our laser vs IPL comparison covers how the two light-based options differ.
Frequently Asked Questions
Are brimonidine and oxymetazoline available without a prescription?
No. Both are prescription-only topical treatments in the UK and US. A clinician needs to assess your skin before either is prescribed.
How long does the redness reduction last?
For most people the effect lasts several hours before gradually wearing off. It varies between individuals, which is one reason logging your response day to day is useful.
Which one is more likely to cause rebound redness?
Rebound or worsening redness after the effect wears off has been reported more often with brimonidine, though it can happen with either. A prescriber can help you weigh this up before you start.
Do they treat bumps, pustules, or the underlying rosacea?
No. They temporarily reduce visible redness only. They have no meaningful effect on papules, pustules, or the underlying inflammatory process, so they are usually combined with other treatment rather than used alone.
See Whether It Is Actually Helping
The honest test of a redness treatment is not how your face looks two hours after applying it. It is what your redness does over weeks: on treatment days, on skipped days, and in the evenings afterwards. Logging redness day to day makes that pattern visible, so you can tell your prescriber what is genuinely helping rather than guessing.
Brimonidine and oxymetazoline are prescription-only medicines. This page is general information, not medical advice, and it is not an instruction to start, stop, or change any treatment. If you think one of these might suit your redness, discuss it with a GP or dermatologist who can examine your skin and weigh the benefits and risks for you.